SEC Form 4 · accession 0001209191-16-095497
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric J. Rey
Officer — President and CEO · Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Feb 1, 2016 | S | 3,000 | $2.9313 | D | 140,380 | D | |
| Common Stock | Feb 3, 2016 | S | 200 | $2.78 | D | 140,180 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective December 14, 2015.
- F2This transaction was executed in multiple trades at prices ranging from $2.80 to $3.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3Includes 750 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 1, 2016.